Previous 10 | Next 10 |
Tencent reported a lackluster FQ4 earnings card. However, management offered cautiously optimistic guidance from H2'22. Notably, we think it represented a clear departure from the uncertainty in its previous earnings commentary. As such, we encourage Tencent investors to add expos...
Baidu (NASDAQ:BIDU) said on Thursday that it was "actively exploring possible solutions" after the Securities and Exchange Commission added the Chinese internet giant to a list of companies that could be delisted from U.S. exchanges. "Baidu will continue to comply with applicable laws and reg...
Baker Brothers’ 13F portfolio value decreased from $22.77B to $20.55B this quarter. Incyte and Legend Biotech stakes were increased this quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~63% of the portfolio. For f...
HQH has a strong and steady dividend history, supported by its earnings. HQH’s stock has performed poorly over the past 5 years, but over the long run it has generated stable price growth. Current price multiples and NAV indicates HQH is trading at a discount. For fur...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The United States has started implementing the provisions of a new law, the Holding Foreign Companies Accountable Act (HFCAA) which causes the delisting of Chinese companies from American stock exchanges if their audit reco...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today has been a relatively exciting day in the world of stocks. For investors in Chinese stocks, perhaps too exciting. Source: Akarat Phasura / Shutterstock.com A range of Chinese stocks are trading much lower t...
Weibo (NASDAQ:WB) shares plunged sharply in mid-day trading on Wednesday after the Securities and Exchange Commission added the Chinese tech company to the list of companies on its Holding Foreign Companies Accountable Act. Shares of Weibo, which is akin to Twitter, fell more than 3...
Alibaba announced a new massive $25B stock buyback program. It replaced its previous $15B authorization. After last week's massive capitulation in Chinese tech stocks, China has also been following up with policy adjustments. We discuss why we revised our rating on BABA stock to S...
It has been a turbulent ride for NIO this year, especially over the past week as Chinese stocks experienced both the worst sell-off and biggest jump since 2008. Earlier this week, NIO posted sharp multi-day plunges following renewed concerns over delisting and regulatory risks. Th...
BeiGene (NASDAQ: BGNE) , a Chinese biopharmaceutical company, saw its shares rise 33.7% on Wednesday. The stock closed at $146.52 on Tuesday but opened at $175.82 today and rose as high as $195.95 in the first hour of trading. So far this year, the stock is still down more than 45%....
News, Short Squeeze, Breakout and More Instantly...
$800 million investment in New Jersey supports global growth and expansion with technologically advanced manufacturing capacity and clinical development capabilities for novel cancer medicines BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today ann...
2024-07-20 02:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BeiGene , Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced the appointment of Aaron Rosenberg as Chief Financial Officer, effective July 22. Mr. Rosenberg will succeed Julia Wang, who is departing to pursue external opportunities and will stay with the C...